Infectious complications in the cancer patient.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D000998:Antiviral Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D002648:Child; D005260:Female; D005334:Fever / Q000150:complications / Q000628:therapy; D006801:Humans; D017053:Infection Control; D007239:Infections / Q000150:complications* / Q000209:etiology; D007938:Leukemia / Q000150:complications; D008297:Male; D009181:Mycoses / Q000150:complications / Q000188:drug therapy; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D009503:Neutropenia / Q000150:complications; D010272:Parasitic Diseases / Q000150:complications; D011528:Protozoan Infections / Q000150:complications; D014777:Virus Diseases / Q000150:complications / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents